Viewing StudyNCT00510029



Ignite Creation Date: 2024-05-05 @ 6:36 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00510029
Status: COMPLETED
Last Update Posted: 2008-03-13
First Post: 2007-07-31

Brief Title: Single Ascending Dose Study of the Safety Tolerability and Pharmacokinetics of GAP-134 Administered Intravenously
Sponsor:
Organization: Wyeth is now a wholly owned subsidiary of Pfizer